@misc{indiciae3d7cfb178ec5,
  title = {Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance},
  author = {Phan, T. and Ribeiro, R. and Edelstein, G. E. and Boucau, J. and Uddin, R. and Marino, C. and Liew, M. Y. and Barry, M. and Choudhary, M. C. and Tien, D. and Su, K. and Reynolds, Z. and Li, Y. and Sagar, S. and Vyas, T. D. and Kawano, Y. and Sparks, J. A. and Hammond, S. P. and Wallace, Z. and Vyas, J. M. and Li, J. Z. and Siedner, M. J. and Barczak, A. K. and Lemieux, J. E. and Perelson, A. S.},
  year = {2024},
  doi = {10.1101/2024.09.13.613000},
  url = {https://www.biorxiv.org/content/10.1101/2024.09.13.613000v1},
  note = {Source identifier: 10.1101/2024.09.13.613000}
}